CME Ups Bid for GFI as Vote Looms
CME Group now offering $5.85 per share for interdealer broker.
The firm has delivered an executed agreement to GFI's special committee, which has been set up to review the various bids, with the revised offer.
The move is in direct response to bids by rival suitor BGC Partners, which submitted a $5.85-per-share all-cash tender offer late last week, contingent on GFI's board acknowledging its bid as a superior proposal. The non-contingent amount was also raised to $5.75.
CME Group itself will not be contributing additional consideration to the offer, but the money will instead come from a forfeiture of the raised amount, up from $5.25 (and later $5.60), by the management consortium, which is giving up approximately $40 million.
The last few days have seen a furious back-and-forth between BGC, CME and GFI, which have been battling for nearly six months over the future of the broker.
At the heart of CME's interest are GFI's two technology businesses, Trayport and Fenics, which handle trading in energy and foreign exchange.
The CME deal would see GFI merged with a subsidiary, with the brokerage arm then being sold to the management consortium as part of a two-step acquisition.
A shareholder vote is being held on January 27, in order to approve or reject the CME Group deal.
GFI was most recently trading at $5.785 per share on Nasdaq (1015 ET). The firm's share price when the deal with CME Group was first proposed, in late July 2014, was $3.11.
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe
You are currently unable to print this content. Please contact info@waterstechnology.com to find out more.
You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@waterstechnology.com
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@waterstechnology.com
More on Emerging Technologies
T. Rowe Price’s Tasitsiomi on the pitfalls of data and the allures of AI
The asset manager’s head of AI and investments data science gets candid on the hype around generative AI and data transparency.
As vulnerability patching gets overwhelming, it’s no-code’s time to shine
Waters Wrap: A large US bank is going all in on a no-code provider in an effort to move away from its Java stack. The bank’s CIO tells Anthony they expect more CIOs to follow this dev movement.
J&J debuts AI data contracts management tool
J&J’s new GARD service will use AI to help data pros query data contracts and license agreements.
An AI-first approach to model risk management
Firms must define their AI risk appetite before trying to manage or model it, says Christophe Rougeaux
Waters Wavelength Ep. 297: How to talk to the media
This week, Tony and Wei-Shen discuss the dos and don’ts for sources interacting with the media.
The Waters Cooler: Tidings of comfort and joy
Christmas is almost upon us. Have you been naughty or nice?
FactSet launches conversational AI for increased productivity
FactSet is set to release a generative AI search agent across its platform in early 2025.
Waters Wavelength Ep. 295: Vision57’s Steve Grob
Steve Grob joins the podcast to discuss all things interoperability, AI, and the future of the OMS.